Clinical Trial Update: A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating avelumab alone or with pegylated liposomal doxorubicin versus doxorubicin alone in platinum-resistant/refractory ovarian cancer; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avelumab (avelumab)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: Pfizer | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-11-19